New Jersey A5020 bans spread pricing by pharmacy benefit managers and mandates transparency in their services.

New Jersey A5020 prohibits pharmacy benefit managers from using spread pricing in their contracts with carriers, health benefits plans, and pharmacies. Spread pricing occurs when the contracted price for prescription drugs differs from the amount paid to pharmacies. The bill mandates that pharmacy benefit managers remit 100 percent of rebates, fees, discounts, and other remuneration to the carrier, health benefits plan, or purchaser.

New Jersey A5020 bans spread pricing by pharmacy benefit managers and mandates transparency in their services.

New Jersey A5020 prohibits pharmacy benefit managers from using spread pricing in their contracts with carriers, health benefits plans, and pharmacies. Spread pricing occurs when the contracted price for prescription drugs differs from the amount paid to pharmacies. The bill mandates that pharmacy benefit managers remit 100 percent of rebates, fees, discounts, and other remuneration to the carrier, health benefits plan, or purchaser.